PARP1 and B-cell non-Hodgkin lymphoma: Previous studies have determined that mice deficient for PARP-1 have increased levels of Tregs [28,29], which may have contributed at least in part to the acceleration of tumourigenesis in the absence of PARP-1 in a c-Myc-driven B cell lymphoma mouse model [30].